Electroceuticals: Technologies and Global Markets

Jul 2022| MDS001B| BCC Publishing
Sample Report

Report Highlights

The global electroceuticals market should reach $25.5 billion by the end of year 2022 and should reach more than $35.5 billion by year 2027, with a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2022-2027.

Report Includes

  • 19 data tables and 24 additional tables
  • An overview of global markets and technologies for electroceuticals
  • Analyses of global market trends, with data from 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Discussion on how electroceuticals are used as an alternative to drug-based remedies and analyses of endogenous and exogenous factors that are impacting the global market growth
  • Coverage of several diseases such as epilepsy, cardiovascular diseases, rheumatoid arthritis and diabetes and their treatment using electroceuticals
  • Information on RecoveryRx medical device, which is used for the treatment of postoperative pain of opioid/NSAID therapy
  • Coverage of regulatory landscape, product recalls, pipeline products, and discussion on future perspective, strategies, and developments of the industry
  • Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market trends, market size, and forecast
  • Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies and a relevant patent analysis
  • Company profiles of major players Abbott Laboratories, Boston Scientific, GlaxoSmithKline plc, Medtronic plc, Edwards Lifesciences Corp.

Report Scope

This report highlights the current and future market potential for electroceuticals. It provides a detailed analysis of the competitive environment, regulatory scenario, and the drivers, restraints, opportunities, and trends in the market. The report also offers market projections through 2027.

This report covers the overall electroceuticals market, including cardiac pacemakers, implantable cardiac defibrillators, hearing aids and implants, and neurostimulation devices. The report also analyzes various end users of electroceuticals.

For this report, the market has been segmented into North America, Europe, Asia-Pacific and the Rest of the World (RoW), which includes Latin America, the Middle East and Africa). Major countries, including the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India) are analyzed. Market data was provided for 2020, which served as the base year, and forecasts are estimated through 2027. Estimated values are based on product manufacturers' total revenues. Projected and forecast revenue values are in constant U.S. dollars that have not been adjusted for inflation.

Analyst Credentials

BCC Publishing Staff comprises expert analysts who are skilled in conducting primary research, secondary research and data analysis and have decades of combined experience covering a wide range of industries, including healthcare, advanced materials and emerging technologies. Collectively, the team represents a diverse set of educational achievements with individual graduate work completed in fields such as microbiology, electrical engineering, business administration and surgery, among others.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesPrice Member Price
Full Report: Electroceuticals: Technologies and Global Markets117 $5,500 Free
Chapter- 1: Introduction7Free DownloadFree
Chapter- 2: Executive Summary3$250Free
Chapter- 3: Overview12$569Free
Chapter- 4: Market Dynamics8$379Free
Chapter- 5: Impact of COVID-19 Pandemic3$142Free
Chapter- 6: Global Market for Electroceuticals by Product12$569Free
Chapter- 7: Global Market for Electroceuticals by End User5$237Free
Chapter- 8: Global Market for Electroceuticals by Region11$522Free
Chapter- 9: Patent Review28$1,328Free
Chapter- 10: Competitive Landscape7$332Free
Chapter- 11: Company Profiles20$948Free
Chapter- 12: Appendix: Acronyms1$47Free
Published - Dec-2019| Analyst - Anuj Pathak| Code - MDS001A

Report Highlights

The global market for electroceuticals should grow from $27.6 billion in 2019 to $39.2 billion by 2024 at a compound annual growth rate (CAGR) of 7.3% for the period of 2019-2024.

Report Includes

  • 29 data tables and 24 additional tables
  • An overview of global markets and technologies for electroceuticals
  • Analyses of global market trends, with data from 2018, estimates for 2019, and projections of compound annual growth rates (CAGRs) through 2024
  • Discussion on why electroceuticals are considered as an alternative to drug-based remedies
  • Identification of endogenous and exogenous factors that are impacting the global market growth
  • Coverage of several diseases such as epilepsy, cardiovascular diseases, rheumatoid arthritis and diabetes and their treatment using electroceuticals
  • Information on RecoveryRx medical device, which is used for the treatment of postoperative pain of opioid/NSAID therapy
  • Comprehensive profiles of leading companies in the industry, including Abbott Laboratories Inc., Biotronik Inc., Cochlear Corp., GlaxoSmithKline Plc and Sonova AG
Electroceuticals: Technologies and Global Markets

Single User License: $5500

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS